Predictors of Seizure Freedom in Pediatric Low-Grade Gliomas

Hailey C Budnick1, Shawyon Baygani1, Teresa Easwaran2

  • 1Neurological Surgery, Indiana University School of Medicine, Indianapolis, USA.

Cureus
|December 29, 2022
PubMed

Insights

Pediatric low-grade gliomas (LGGs) are often linked to epilepsy. Patients not presenting with seizures and those receiving prophylactic antiepileptic drugs (AEDs) showed better seizure freedom after surgery.

Area of Science:

  • Pediatric Neurosurgery
  • Pediatric Neurology
  • Neuro-oncology

Background:

  • Pediatric low-grade gliomas (LGGs) are a significant cause of medically refractory epilepsy in children.
  • Understanding predictors of seizure freedom is crucial for managing this patient population.

Purpose of the Study:

  • To identify predictors of seizure freedom in pediatric patients with low-grade gliomas undergoing surgical management.
  • To investigate factors associated with seizure control post-operatively in pediatric LGGs.

Main Methods:

  • Retrospective chart review of pediatric patients (≤18 years) with WHO Grade I and II gliomas (2007-2017).
  • Exclusion of infratentorial and purely intraventricular lesions.
  • Analysis of tumor characteristics, seizure status, and antiepileptic drug (AED) use, with Chi-squared analyses controlling for relevant variables.

Main Results:

  • Preoperative seizures were associated with persistent seizure burden post-operatively, irrespective of resection extent.
  • Supratentorial location and prophylactic pre- and post-operative AEDs correlated with Engel Class I seizure freedom.
  • Temporal lobe location was not significantly linked to medically refractory epilepsy.

Conclusions:

  • Absence of preoperative seizures and prophylactic AEDs predict better seizure freedom (Engel Class I) in pediatric LGGs.
  • Tumor location (temporal vs. extra-temporal) did not significantly impact seizure burden.
  • Extent of resection and electrocorticography did not correlate with improved seizure freedom outcomes.
Abstract

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
521
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
241
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
397